(Press-News.org) PHILADELPHIA—The Pew Charitable Trusts announced today the eight pairs of researchers who will make up its 2024 class of Innovation Fund investigators.
These 16 acclaimed scientists—all alumni of Pew’s biomedical programs in the United States and Latin America—will collaborate on interdisciplinary research projects that explore foundational questions about human biology and disease. By combining their expertise in topic areas ranging from cell biology and immunology to neuroscience and genetics, these partnerships will help to advance scientific discovery and improve human health.
“Now more than ever, interdisciplinary approaches are key to solving the world’s most pressing scientific challenges,” said Donna Frisby-Greenwood, Pew’s senior vice president for Philadelphia and scientific advancement. “Through their innovative research projects, these exceptional investigators are drawing on their different areas of scientific inquiry to advance biomedical research, and Pew is proud to support them.”
For nearly 40 years, Pew has encouraged collaboration among its diverse community of biomedical scientists, leading to the 2017 launch of the Innovation Fund. The award, which is supported by the Kathryn W. Davis Peace by Pieces Fund, was developed to support creative and cross-disciplinary partnerships among alumni of Pew’s three biomedical programs, with those holding assistant professor positions or higher eligible to apply. The project is also made possible in part this year by a grant from the Chan Zuckerberg Initiative Foundation.
This year’s Innovation Fund teams and research projects are:
Maria Barna, Ph.D., 2014 Pew biomedical scholar; Stanford University
Christine M. Dunham, Ph.D., 2011 Pew biomedical scholar; Emory University
Barna and Dunham will examine how small molecules called ribosomes increase global protein synthesis, a largely unknown mechanism with the power to alleviate the effects of human disease.
Ilana L. Brito, Ph.D., 2018 Pew biomedical scholar; Cornell University
Gabriel Victora, Ph.D., 2019 Pew-Stewart scholar; The Rockefeller University
Brito and Victora will explore the interactions between gut microbiota and intestinal immune cells by way of germinal centers—structures where specialized immune cells undergo selection and maturation to produce antibodies.
Daiana A. Capdevila, Ph.D., 2016 Pew Latin American fellow; Fundación Instituto Leloir
Ana S. Peinetti, Ph.D., 2017 Pew Latin American fellow; Instituto de Química Física de los Materiales, Medio Ambiente y Energía (CONICET-Universidad de Buenos Aires)
Capdevila and Peinetti will develop a low-cost, in vitro transcription-based diagnostic platform to detect the presence of viral antigens in serum samples of people infected with insect-borne arboviruses.
Kimberly L. Cooper, Ph.D., 2015 Pew biomedical scholar; University of California, San Diego
Elizabeth Villa, Ph.D., 2017 Pew biomedical scholar; University of California, San Diego
Cooper and Villa aim to resolve how chondrocytes—specialized cells at the ends of bones—function during bone growth.
K. Christopher Garcia, Ph.D., 2001 Pew biomedical scholar; Stanford University
Jesse D. Bloom, Ph.D., 2015 Pew biomedical scholar; Fred Hutch Cancer Center
Garcia and Bloom will explore and exploit protein-protein recognition critical for adaptive immunity, using a novel co-evolution platform to better understand protein binding and engineer antibodies that can better respond to rapidly mutating viruses.
Jonathon Howard, Ph.D., 1990 Pew biomedical scholar; Yale University
Tomás L. Falzone, Ph.D., 2002 Pew Latin American fellow; IBioBA-MPSP-CONICET; Facultad de Medicina, Universidad de Buenos Aires
Howard and Falzone will uncover how the diameters of dendrites and axons support the demands of optimal neuronal function, providing foundational knowledge about the inner workings of the brain and neurodegeneration.
Michael S. Kuhns, Ph.D., 2011 Pew biomedical scholar; University of Arizona
Nels C. Elde, Ph.D., 2012 Pew biomedical scholar; University of Utah
Kuhns and Elde will study the functional consequences of interspecies differences in the structure of immunoglobulin domains—protein building blocks that are key for mediating immunity across species.
Seth Rakoff-Nahoum, M.D., Ph.D., 2018 Pew biomedical scholar; Boston Children's Hospital, Harvard Medical School
Jing-Ke Weng, Ph.D., 2014 Pew biomedical scholar; Northeastern University
Rakoff-Nahoum and Weng seek to redefine the intricate relationship between food and health by using isotopic labeling to precisely trace food molecules’ pathways, modifications, and host interactions.
Founded in 1948, The Pew Charitable Trusts uses data to make a difference. Pew addresses the challenges of a changing world by illuminating issues, creating common ground, and advancing ambitious projects that lead to tangible progress.
END
Pew funds 8 teams to conduct collaborative biomedical research
2024-12-10
ELSE PRESS RELEASES FROM THIS DATE:
Finding innovative ways to address kidney cancer leads to DoD grant
2024-12-10
Weill Cornell Medicine has received a $1.4 million, four-year grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.
The grant is one of 10 Idea Awards the department funded this year to support innovative, high-risk, high-reward science that could lead to a paradigm shift in cancer care. The funding will enable principal investigators Dr. Lorraine Gudas and Dr. David Nanus to explore a cellular reprogramming strategy that may improve how patients ...
Americans are uninformed about and undervaccinated for HPV
2024-12-10
LOS ANGELES — The human papillomavirus (HPV), a common sexually transmitted infection, accounts for 70% of all throat cancers, according to the National Cancer Institute. While commonly associated with cervical cancer, throat cancer is now the most common type of HPV-related cancer.
However, the majority of American adults are unaware that HPV can cause throat cancer and are not taking advantage of the one proven method for prevention — the HPV vaccine.
These are the conclusions of two recent studies from the USC Head and Neck Center, part of Keck Medicine of USC and the USC Caruso Department of Otolaryngology – ...
KTU scientists developed a nanolaser: silver nanocubes enable light generation
2024-12-10
Kaunas University of Technology (KTU), Lithuania researchers and scientists from Japan have developed a unique nanolaser. Although the dimensions of this laser are so small that its structure can only be seen through a powerful microscope, its potential is vast. With applications in early medical diagnostics, data communication, and security technologies, this invention could also become a key tool for the study of light and matter interactions.
Depending on the application, lasers differ in the way light is amplified and produced, which determines the colour of the radiation and the quality of the laser ...
Insilico Medicine nominates orally available pre-clinical candidate targeting NLRP3 to treat inflammation and central nervous system diseases
2024-12-10
As the first line against microbial infections or endogenous cellular damage in our body, the innate immune system utilizes NLRs (NOD-like receptors) to sense the molecules triggering microbial infection and damage, thus ensuring the proper immune response function. In the NLRs family, NLRP3 is the most characterized member, and its overactivation can lead to excessive production of pro-inflammatory cytokines and chemokines, driving pathological processes in various inflammatory diseases.
CAMBRIDGE, Mass., Dec 10, 2024 --- Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery ...
PLOS receives $3.3 million grant to support Open Access publishing & business model transformation
2024-12-10
SAN FRANCISCO — FOR IMMEDIATE RELEASE
PLOS has been awarded a $3.3million grant from the Bill & Melinda Gates Foundation, underscoring its commitment to pioneer a shift away from traditional publishing models. The 3-year funding package from the Gates Foundation will support PLOS’ transition towards APC-free publishing by enabling authors, funded by the foundation, to publish with PLOS without facing APC barriers, and to contribute to open access publishing options for authors who do not have access to funding. This 3-year grant offers support while PLOS is actively working on new publishing models grounded in open science starting with ...
HBx facilitates drug resistance in hepatocellular carcinoma via CD133-regulated self-renewal of liver cancer stem cells
2024-12-10
Background and Aims
Hepatitis B virus (HBV) infection contributes to hepatocellular carcinoma (HCC) tumorigenesis, drug resistance, and recurrence, although the underlying molecular mechanisms remain unclear. Recent studies suggest that HBV infection may be associated with liver cancer stem cells (LCSCs), but the exact mechanisms are yet to be resolved. In this study, we aimed to analyze the role of HBV infection in regulating the stemness of HCCs, which is closely linked to drug resistance.
Methods
Sphere formation assay and real-time Polymerase Chain Reaction quantification were used to ...
ASN congratulates members for their role in the development of the Scientific Report of the 2025 Dietary Guidelines Advisory Committee
2024-12-10
Rockville, MD – December 10, 2024 –The American Society for Nutrition (ASN) applauds the release of the Scientific Report of the 2025 Dietary Guidelines Advisory Committee (DGAC). The Society is pleased to note that 19 of the 20 Committee members are ASN members, including the Chair, ASN President Sarah Booth, and Vice Chair, Angela Odoms-Young, a member of the ASN Board of Directors. The DGAC is an independent panel of nutrition science experts tasked to review the state of the evidence on nutrition-related topics and scientific questions identified by the U.S. Department of Agriculture (USDA) ...
Late-stage breast cancer diagnosis on the rise in US
2024-12-10
OAK BROOK, Ill. – The number of women with late-stage, invasive breast cancer at the time of diagnosis increased significantly among U.S. women across all ages and ethnicities between 2004 and 2021, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).
In the study, researchers analyzed the latest available Surveillance, Epidemiology, and End Results (SEER) data on annual stage-specific breast cancer incidence rates between 2004 and 2021. SEER data is collected from 22 population-based ...
Brain volume changes seen in opioid users
2024-12-10
OAK BROOK, Ill. – Researchers at the Yale School of Medicine found structural and functional alterations in specific brain regions of individuals with opioid use disorder. The study’s results were published today in Radiology, a journal of the Radiological Society of North America (RSNA).
Opioids are a class of drugs that include synthetic opioids such as fentanyl, prescription pain relievers like oxycodone, and illegal narcotics, including heroin. Opioids have a high potential for misuse, and opioid use is a major contributor to drug overdoses in the ...
Ultra-processed foods may drive colorectal cancer risk, USF-TGH study finds
2024-12-10
Media Contact:
John Dudley
(814) 490-3290 (cell)
jjdudley@usf.edu
EMBARGOED FOR PUBLICATION UNTIL TUESDAY, DEC. 10, AT 10 A.M. ET
TAMPA, Fla. (Embargoed until Dec. 10, 2024) – Colorectal cancer, the second leading cause of cancer-related deaths in the United States, may be fueled by the food on our plates. Researchers at the University of South Florida and Tampa General Hospital Cancer Institute have uncovered a potential link between the Western diet – dominated by ultra-processed foods and unhealthy oils – and the chronic inflammation that drives ...